Drawing for IMMUNETICS

USPTO serial 87736608

IMMUNETICS

Reviewed by CopyMark Law Group

Reg. 5529903Status 710
Filing date
Status date
Registration date
Jul 31, 2018
Examiner
CALLOWAY, CHRISTINA DENISE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with IMMUNETICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Carrie Webb Olson

Carrie Webb Olson Day Pitney LLPOne Federal Street, 29th FloorBoston, MA 02110United States

Goods and services

ClassDescriptionStatusFirst use
005medical diagnostic reagents; assay kits comprised of chemical, biological and biochemical components for use in medical diagnosis, prognosis and therapeutic monitoringSECTION 8 - CANCELLEDMar 18, 1985

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 14, 2025C8..CANCELLED SEC. 8 (6-YR)—
Jul 28, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 28, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 28, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 28, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 2, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Nov 2, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 2, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 2, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 2, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 2, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 31, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 31, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 15, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 15, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 25, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 11, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 9, 2018DOCKASSIGNED TO EXAMINER—
Jan 12, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 2, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance